Picture of Syndax Pharmaceuticals logo

SNDX — Syndax Pharmaceuticals News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousMid CapSucker Stock

Syndax Pharmaceuticals Inc reports results for the quarter ended in June - Earnings Summary

* Syndax Pharmaceuticals Inc  SNDX.OQ  reported a quarterly
adjusted loss of 80 cents​​ per share for the quarter ended in
June, lower than the same quarter last year, when the company
reported EPS of -64 cents.  The mean expectation of
twelve analysts for the quarter was for a loss of 91 cents per
share. Wall Street expected results to range from -97 cents
to -87 cents per share.
    * Revenue was $3.50 million​; analysts expected zero. 
    * Syndax Pharmaceuticals Inc's reported EPS for the quarter
was a
loss of 80 cents​.
    * The company reported a quarterly loss of $68.06 million.
    * Syndax Pharmaceuticals Inc shares had risen by 10.6% this
quarter and gained 5.0% so far this year.

FORECAST CHANGES
    * The mean earnings estimate of analysts had risen by
about 11.8%
in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.

RECOMMENDATIONS
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 13 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell." 
    * The average consensus recommendation for the biotechnology
&
medical research peer group is also "buy"

Wall Street's median 12-month price target for Syndax
Pharmaceuticals Inc is $35.00 
This summary was machine generated from LSEG data August 2 at
12:02 a.m. UTC. ​All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Jun. 30 2024      -0.91          -0.80          Beat
 Mar. 31 2024      -0.98          -0.85          Beat
 Dec. 31 2023      -0.99          -1.00          Missed
 Sep. 30 2023      -0.80          -0.73          Beat

Recent news on Syndax Pharmaceuticals

See all news